Cargando…
Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells
The poor prognosis of Glioblastoma Multiforme (GBM) is due to a high resistance to conventional treatments and to the presence of a subpopulation of glioma stem cells (GSCs). Combination therapies targeting survival/self-renewal signals of GBM and GSCs are emerging as useful tools to improve GBM tre...
Autores principales: | Daniele, Simona, Costa, Barbara, Zappelli, Elisa, Da Pozzo, Eleonora, Sestito, Simona, Nesi, Giulia, Campiglia, Pietro, Marinelli, Luciana, Novellino, Ettore, Rapposelli, Simona, Martini, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404683/ https://www.ncbi.nlm.nih.gov/pubmed/25898313 http://dx.doi.org/10.1038/srep09956 |
Ejemplares similares
-
Human Glioblastoma Multiforme: p53 Reactivation by a Novel MDM2 Inhibitor
por: Costa, Barbara, et al.
Publicado: (2013) -
Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells
por: Daniele, Simona, et al.
Publicado: (2016) -
Lactate dehydrogenase-A inhibition induces human glioblastoma multiforme stem cell differentiation and death
por: Daniele, Simona, et al.
Publicado: (2015) -
Hydrogen Sulfide: A Worthwhile Tool in the Design of New Multitarget Drugs
por: Sestito, Simona, et al.
Publicado: (2017) -
New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective
por: Sestito, Simona, et al.
Publicado: (2018)